Cargando…
Management of non-small cell lung cancer with resistance to epidermal growth factor receptor tyrosine kinase inhibitor: case discussion
Autores principales: | Zheng, Yuyan, Zhou, Min, Arulananda, Surein, Um, Sang-Won, Li, Hecheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138979/ https://www.ncbi.nlm.nih.gov/pubmed/32274080 http://dx.doi.org/10.21037/jtd.2020.01.65 |
Ejemplares similares
-
Osimertinib as induction therapy for oligometastatic non-small cell lung cancer with EGFR mutation: a case report
por: Wu, Han, et al.
Publicado: (2022) -
Alveolar adenoma of the lung: multidisciplinary case discussion and review of the literature
por: Roshkovan, Leonid, et al.
Publicado: (2020) -
Classical ALK G1202R resistance mutation was identified in a lung adenocarcinoma patient with rare LOC388942-ALK fusion after sequential treatment with ALK-TKIs and anlotinib: a case report
por: Zhai, Xiaoqian, et al.
Publicado: (2022) -
How to optimize the treatment strategy for patients of pulmonary sequestration with an elevated risk of fatal hemorrhage during operation: case discussion
por: Liu, Yu, et al.
Publicado: (2020) -
Rectal gastrointestinal stromal tumor with metachronous liver metastasis demonstrated no relapse after multidisciplinary team discussion and comprehensive treatment: a case report
por: Zhang, Xuan, et al.
Publicado: (2022)